Philippines - English - FDA (Food And Drug Administration)

zuellig pharma corp - live attenuated measles vaccine freeze dried/at least 1000 ccid50/dose schwarz strain (sc/im) - schwarz strain im/sc

Ireland - English - HPRA (Health Products Regulatory Authority)

schwarz pharma limited - isosorbide dinitrate - concentrate for soln for inf - 0.1 %w/v

United States - English - NLM (National Library of Medicine)

schwarz pharma - famotidine (unii: 92psg83j8a) (famotidine - unii:92psg83j8a) - tablet, orally disintegrating - 20 mg - fluxid™ is indicated in: 1. short term treatment of active duodenal ulcer. most adult patients heal within 4 weeks; there is rarely reason to use famotidine at full dosage for longer than 6 to 8 weeks. studies have not assessed the safety of famotidine in uncomplicated active duodenal ulcer for periods of more than eight weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcer. controlled studies in adults have not extended beyond one year. 3. short term treatment of active benign gastric ulcer. most adult patients heal within 6 weeks. studies have not assessed the safety or efficacy of famotidine in uncomplicated active benign gastric ulcer for periods of more than 8 weeks. 4. short term treatment of gastroesophageal reflux disease (gerd) . fluxid™ is indicated for short term treatment of patients with symptoms of gerd (see clinical pharmacology in adults, clinical studies ). fluxid™ is also indicated for the short term treatment of esophagitis due to ge

United States - English - NLM (National Library of Medicine)

schwarz pharma - baclofen (unii: h789n3fke8) (baclofen - unii:h789n3fke8) - tablet, orally disintegrating - 10 mg - kemstro™ is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. patients should have reversible spasticity so that treatment with kemstro™ will aid in restoring residual function. kemstro™ may also be of some value in patients with spinal cord injuries and other spinal cord diseases. kemstro™ is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. the efficacy of kemstro™ in stroke, cerebral palsy, and parkinson's disease has not been established and, therefore, it is not recommended for these conditions. kemstro™ is contraindicated in patients who are hypersensitive to any component of this product. vomiting, muscular hypotonia, drowsiness, accommodation disorders, coma, respiratory depression, and seizures. in the alert patient, empty the stomach promptly by induced emesis followed by lavage. in the obtunded patient, secure th

United States - English - NLM (National Library of Medicine)

schwarz pharma - carbidopa (unii: mnx7r8c5vo) (carbidopa - unii:mnx7r8c5vo), levodopa (unii: 46627o600j) (levodopa - unii:46627o600j) - tablet, orally disintegrating - 25 mg - parcopa®   is indicated in the treatment of the symptoms of idiopathic parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication. parcopa®   is indicated in these conditions to permit the administration of lower doses of levodopa with reduced nausea and vomiting, with more rapid dosage titration, with a somewhat smoother response, and with supplemental pyridoxine (vitamin b6 ). in some patients, a somewhat smoother antiparkinsonian effect results from therapy with carbidopa-levodopa than with levodopa. however, patients with markedly irregular (“on-off”) responses to levodopa have not been shown to benefit from carbidopa-levodopa therapy. although the administration of carbidopa permits control of parkinsonism and parkinson’s disease with much lower doses of levodopa, there is no conclusive evidence at present that this is beneficial other than in reducing naus

United States - English - NLM (National Library of Medicine)

schwarz pharma - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - aerosol, foam - 90 mg in 900 mg - cortifoam® is indicated as adjunctive therapy in the topical treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas. cortifoam® is contraindicated in patients who are hypersensitive to any components of this product. local contraindications to the use of intrarectal steroids include obstruction, abscess, perforation, peritonitis, fresh intestinal anastomoses, extensive fistulas and sinus tracts.

United States - English - NLM (National Library of Medicine)

schwarz pharma - isosorbide dinitrate (unii: ia7306519n) (isosorbide dinitrate - unii:ia7306519n) - capsule, extended release - 40 mg - dilatrate®-sr sustained release capsules are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of controlled-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. allergic reactions to organic nitrates are extremely rare, but they do occur. isosorbide dinitrate is contraindicated in patients who are allergic to it.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

esteve pharmaceuticals ltd - tretinoin - oral capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - tretinoin - oral capsule - 10mg

Canada - English - Health Canada

schwarz pharma, inc. - iron (polysaccharide-iron complex) - capsule - 150mg - iron (polysaccharide-iron complex) 150mg - iron preparations